May 22, 2013 2:37 PM ET

Life Sciences Tools and Services

Company Overview of Quintiles Transnational Corp.

Company Overview

Quintiles Transnational Corp. provides clinical, commercial, consulting, and capital solutions to biopharmaceutical industry. The company’s clinical development services cover trial types, such as phase I/IIa, phase II/III, late phase, medical devices, and emerging biopharmaceutical; trial services, including bioanalytical and ADME laboratory, biostatistics, biosimilars, central laboratory, clinical monitoring, data management, ECG, functional, lifecycle safety, patient and investigator recruitment, medical writing, model-based drug development, regulatory, and site ID and start up; data intelligence services comprising reporting and analytics, data-driven processes, data archival and wareho...

Detailed Description

4820 Emperor Boulevard

Durham, NC 27703-8411

United States

Founded in 1990

Phone:

919-998-2000

Fax:

919-998-2003

Key Executives for Quintiles Transnational Corp.

Chief Executive Officer
Age: 53
President
Age: 52
Executive Chairman and Member of Executive Committee
Age: 68
Chief Financial Officer
Age: 49
Chief Executive Officer of AAA Region and President of AAA Region
Age: 63
Compensation as of Fiscal Year 2012.

Quintiles Transnational Corp. Key Developments

Quintiles Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-11-2013 01:30 PM

Quintiles Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-11-2013 01:30 PM. Venue: Centre Covencions International Barcelona, Plaça de Willy Brandt, 11-14, 08019 Barcelona, Spain. Speakers: Amir Kalali, VP, Therapeutic Strategy Head, Neuroscience.

Cardiome Pharma Corp. Selects Quintiles To Manage Global Regulatory Affairs And Life Cycle Safety Activities For BRINAVESS

Cardiome Pharma Corp. announced the selection of Quintiles to provide comprehensive post-marketing lifecycle safety and global regulatory affairs services for BRINAVESS(TM). Quintiles will begin providing these services effective immediately as Cardiome continues to prepare for the anticipated transfer of BRINAVESS(TM) from Merck to Cardiome.

Quintiles Reportedly Hires Advisors For IPO

Quintiles Transnational Corp. has selected Morgan Stanley, Barclays Plc, and JPMorgan Chase & Co (JPM.N) as joint book runners for a planned initial public offering, people familiar with the matter said. Bain Capital Private Equity and TPG Capital, L.P. are owner of Quintiles. According to Reuters, Bain was not immediately reached for comment, TPG, Morgan Stanley, Barclays and JPMorgan declined comment. The sources have not disclosed the name because the matter is not public.

Similar Private Companies By Industry

Company Name Region
Monogram Biosciences, Inc. United States
Relox Medical, LLC United States
PlantGenix, Inc. United States
Sangart, Inc. United States
Serum Technologies Holdings, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Bankruptcy
July 30, 2012
Curaxis Pharmaceutical Corporation
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Quintiles Transnational Corp., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.